Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.
- M. Riddle, J. Rosenstock, J. Gerich
- Medicine
- Diabetes care
- 1 November 2003
OBJECTIVE
To compare the abilities and associated hypoglycemia risks of insulin glargine and human NPH insulin added to oral therapy of type 2 diabetes to achieve 7% HbA(1c).
RESEARCH DESIGN AND… Expand
Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
OBJECTIVE To determine the efficacy and safety of liraglutide (a glucagon-like peptide-1 receptor agonist) when added to metformin and rosiglitazone in type 2 diabetes. RESEARCH DESIGN AND METHODS… Expand
Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications
- J. Gerich
- Medicine
- Diabetic medicine : a journal of the British…
- 1 February 2010
Diabet. Med. 27, 136–142 (2010)
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.
- M. Stumvoll, N. Nurjhan, G. Perriello, G. Dailey, J. Gerich
- Medicine
- The New England journal of medicine
- 31 August 1995
BACKGROUND
The metabolic effects and mechanism of action of metformin are still poorly understood, despite the fact that it has been used to treat patients with non-insulin-dependent diabetes… Expand
Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction.
- A. Mitrakou, C. Ryan, +6 authors J. Gerich
- Biology, Medicine
- The American journal of physiology
- 1991
To define glycemic thresholds for activation of counterregulatory hormone secretion, initiation of symptoms (autonomic and neuroglycopenic), and onset of deterioration of cognitive function, we… Expand
Renal gluconeogenesis: its importance in human glucose homeostasis.
- J. Gerich, C. Meyer, H. Woerle, M. Stumvoll
- Medicine
- Diabetes care
- 1 February 2001
Studies conducted over the last 60 years in animals and in vitro have provided considerable evidence that the mammalian kidney can make glucose and release it under various conditions. Until quite… Expand
Dose-response characteristics for effects of insulin on production and utilization of glucose in man.
- R. Rizza, L. Mandarino, J. Gerich
- Biology, Medicine
- The American journal of physiology
- 1 June 1981
To determine the dose-response characteristics for the effects of insulin on glucose production, glucose utilization, and overall glucose metabolism in normal man, 15 healthy subjects were infused… Expand
The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity.
- J. Gerich
- Medicine
- Endocrine reviews
- 1 August 1998
Despite the fact that it is the prevalent view that insulin resistance is the main genetic factor predisposing to development of type 2 diabetes, review of several lines of evidence in the literature… Expand
The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications.
- B. Dunning, J. Gerich
- Medicine
- Endocrine reviews
- 2007
The hyperglycemic activity of pancreatic extracts was encountered some 80 yr ago during efforts to optimize methods for the purification of insulin. The hyperglycemic substance was named "glucagon,"… Expand
Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus.
- P. Campbell, L. Mandarino, J. Gerich
- Medicine
- Metabolism: clinical and experimental
- 1988
In non-insulin-dependent diabetes mellitus (NIDDM), both liver and peripheral tissues are resistant to insulin, but the relative severity and contribution of these abnormalities to fasting… Expand